Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 28 uM | Displacement of [125I]NDP-MSH from human recombinant MC5 receptor expressed in Sf9 cells | ChEMBL. | 17618123 |
Ki (binding) | = 28 uM | Displacement of [125I]NDP-MSH from human recombinant MC5 receptor expressed in Sf9 cells | ChEMBL. | 17618123 |
Ki (binding) | = 35 uM | Displacement of [125I]NDP-MSH from MC1 receptor in mouse B16 cells | ChEMBL. | 17618123 |
Ki (binding) | = 35 uM | Displacement of [125I]NDP-MSH from MC1 receptor in mouse B16 cells | ChEMBL. | 17618123 |
Ki (binding) | = 150 uM | Displacement of [125I]NDP-MSH from human recombinant MC4 receptor expressed in Sf9 cells | ChEMBL. | 17618123 |
Ki (binding) | = 150 uM | Displacement of [125I]NDP-MSH from human recombinant MC4 receptor expressed in Sf9 cells | ChEMBL. | 17618123 |
Ki (binding) | = 228 uM | Displacement of [125I]NDP-MSH from human recombinant MC3 receptor expressed in Sf9 cells | ChEMBL. | 17618123 |
Ki (binding) | = 228 uM | Displacement of [125I]NDP-MSH from human recombinant MC3 receptor expressed in Sf9 cells | ChEMBL. | 17618123 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.